We've found
15,024
archived clinical trials in
Infectious Disease
We've found
15,024
archived clinical trials in
Infectious Disease
Love, Sex & Choices: A Web Series on Mobile Devices to Reduce Black Women's HIV Risk
Updated: 3/27/2018
Reducing Urban Women's HIV Risk: Soap Opera Videos on Mobile Devices
Status: Enrolling
Updated: 3/27/2018
Love, Sex & Choices: A Web Series on Mobile Devices to Reduce Black Women's HIV Risk
Updated: 3/27/2018
Reducing Urban Women's HIV Risk: Soap Opera Videos on Mobile Devices
Status: Enrolling
Updated: 3/27/2018
Click here to add this to my saved trials
ARMS-I (a Formulation of Cetylpyridinium Chloride -CPC)
Updated: 3/27/2018
Evaluation of the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Orally Administered ARMS-I Administered in Healthy Adults, Aged 18-45 Years
Status: Enrolling
Updated: 3/27/2018
ARMS-I (a Formulation of Cetylpyridinium Chloride -CPC)
Updated: 3/27/2018
Evaluation of the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Orally Administered ARMS-I Administered in Healthy Adults, Aged 18-45 Years
Status: Enrolling
Updated: 3/27/2018
Click here to add this to my saved trials
Retapamulin for Reducing MRSA Nasal Carriage
Updated: 3/29/2018
Retapamulin for Reducing MRSA Nasal Carriage
Status: Enrolling
Updated: 3/29/2018
Retapamulin for Reducing MRSA Nasal Carriage
Updated: 3/29/2018
Retapamulin for Reducing MRSA Nasal Carriage
Status: Enrolling
Updated: 3/29/2018
Click here to add this to my saved trials
Evaluating Modes of Influenza Transmission Observational Study of Community Acquired Influenza
Updated: 3/29/2018
Evaluating Modes of Influenza Transmission Work Package 1: Observational Study of Community Acquired Influenza
Status: Enrolling
Updated: 3/29/2018
Evaluating Modes of Influenza Transmission Observational Study of Community Acquired Influenza
Updated: 3/29/2018
Evaluating Modes of Influenza Transmission Work Package 1: Observational Study of Community Acquired Influenza
Status: Enrolling
Updated: 3/29/2018
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Click here to add this to my saved trials
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Updated: 3/29/2018
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
Status: Enrolling
Updated: 3/29/2018
Click here to add this to my saved trials
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Updated: 3/30/2018
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated: 3/30/2018
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Updated: 3/30/2018
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated: 3/30/2018
Click here to add this to my saved trials
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Updated: 3/30/2018
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated: 3/30/2018
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Updated: 3/30/2018
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated: 3/30/2018
Click here to add this to my saved trials
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Updated: 3/30/2018
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated: 3/30/2018
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Updated: 3/30/2018
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated: 3/30/2018
Click here to add this to my saved trials
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Updated: 3/30/2018
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated: 3/30/2018
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Updated: 3/30/2018
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated: 3/30/2018
Click here to add this to my saved trials
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Updated: 3/30/2018
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated: 3/30/2018
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Updated: 3/30/2018
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated: 3/30/2018
Click here to add this to my saved trials
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Updated: 3/30/2018
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated: 3/30/2018
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Updated: 3/30/2018
Safety and Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A in Adult HIV-infected Subjects
Status: Enrolling
Updated: 3/30/2018
Click here to add this to my saved trials
Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older
Updated: 3/30/2018
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 3/30/2018
Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older
Updated: 3/30/2018
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 3/30/2018
Click here to add this to my saved trials
Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older
Updated: 3/30/2018
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 3/30/2018
Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older
Updated: 3/30/2018
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 3/30/2018
Click here to add this to my saved trials
Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older
Updated: 3/30/2018
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 3/30/2018
Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older
Updated: 3/30/2018
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 3/30/2018
Click here to add this to my saved trials
Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older
Updated: 3/30/2018
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 3/30/2018
Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older
Updated: 3/30/2018
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 3/30/2018
Click here to add this to my saved trials
Enhance Wellness for Individuals With Long-Term Physical Disabilities
Updated: 3/30/2018
Project Enhance for Adults Aging With Long-Term Physical Disability
Status: Enrolling
Updated: 3/30/2018
Enhance Wellness for Individuals With Long-Term Physical Disabilities
Updated: 3/30/2018
Project Enhance for Adults Aging With Long-Term Physical Disability
Status: Enrolling
Updated: 3/30/2018
Click here to add this to my saved trials
Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of Age
Updated: 3/30/2018
Phase I Evaluation of the Safety and Immunogenicity of an Investigational Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naïve Adults 50 - 70 Years of Age
Status: Enrolling
Updated: 3/30/2018
Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of Age
Updated: 3/30/2018
Phase I Evaluation of the Safety and Immunogenicity of an Investigational Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naïve Adults 50 - 70 Years of Age
Status: Enrolling
Updated: 3/30/2018
Click here to add this to my saved trials
Scrambler Therapy in Treating Chronic Pain in Patients With Rash From Varicella Zoster Virus Infection
Updated: 4/2/2018
Scrambler Therapy for the Treatment of Chronic Zoster Pain
Status: Enrolling
Updated: 4/2/2018
Scrambler Therapy in Treating Chronic Pain in Patients With Rash From Varicella Zoster Virus Infection
Updated: 4/2/2018
Scrambler Therapy for the Treatment of Chronic Zoster Pain
Status: Enrolling
Updated: 4/2/2018
Click here to add this to my saved trials
Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers
Updated: 4/3/2018
Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers
Status: Enrolling
Updated: 4/3/2018
Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers
Updated: 4/3/2018
Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis
Updated: 4/3/2018
Micro-processor Controlled Knee-Ankle-Foot Orthosis (C-Brace) Versus Stance-control Knee-Ankle-Foot Orthosis (SCO): Functional Outcomes in Individuals With Lower Extremity Impairment
Status: Enrolling
Updated: 4/3/2018
Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis
Updated: 4/3/2018
Micro-processor Controlled Knee-Ankle-Foot Orthosis (C-Brace) Versus Stance-control Knee-Ankle-Foot Orthosis (SCO): Functional Outcomes in Individuals With Lower Extremity Impairment
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Product X92001327 vs RID Shampoo in Subjects With Head Lice
Updated: 4/3/2018
A Randomized, Controlled, Investigator-blinded, Comparative Study to Evaluate the Safety and Efficacy of Product X92001327 vs RID Shampoo in Subjects With Head Lice
Status: Enrolling
Updated: 4/3/2018
A Study to Evaluate the Safety and Efficacy of Product X92001327 vs RID Shampoo in Subjects With Head Lice
Updated: 4/3/2018
A Randomized, Controlled, Investigator-blinded, Comparative Study to Evaluate the Safety and Efficacy of Product X92001327 vs RID Shampoo in Subjects With Head Lice
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
Antibiotic Outbreak, Risk Factors for Never Event, Prediction of Inappropriate Use
Updated: 4/3/2018
A Retrospective Study to Understand the Risk Factors/Drivers of "Inappropriate" Antimicrobial Use and the Performance Evaluation of a Clinical Decision Support Tool That Facilitates Prediction of Outbreaks of Inappropriate Antibiotic Use
Status: Enrolling
Updated: 4/3/2018
Antibiotic Outbreak, Risk Factors for Never Event, Prediction of Inappropriate Use
Updated: 4/3/2018
A Retrospective Study to Understand the Risk Factors/Drivers of "Inappropriate" Antimicrobial Use and the Performance Evaluation of a Clinical Decision Support Tool That Facilitates Prediction of Outbreaks of Inappropriate Antibiotic Use
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
Immune Response to Mycobacterium Tuberculosis Infection
Updated: 4/4/2018
Correlation of the Precursor Frequency of CD4 + Effector Memory T Cells With Induration Measured in the Tuberculin Skin Test (TST)
Status: Enrolling
Updated: 4/4/2018
Immune Response to Mycobacterium Tuberculosis Infection
Updated: 4/4/2018
Correlation of the Precursor Frequency of CD4 + Effector Memory T Cells With Induration Measured in the Tuberculin Skin Test (TST)
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Immune Response to Mycobacterium Tuberculosis Infection
Updated: 4/4/2018
Correlation of the Precursor Frequency of CD4 + Effector Memory T Cells With Induration Measured in the Tuberculin Skin Test (TST)
Status: Enrolling
Updated: 4/4/2018
Immune Response to Mycobacterium Tuberculosis Infection
Updated: 4/4/2018
Correlation of the Precursor Frequency of CD4 + Effector Memory T Cells With Induration Measured in the Tuberculin Skin Test (TST)
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections
Updated: 4/4/2018
Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections
Status: Enrolling
Updated: 4/4/2018
Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections
Updated: 4/4/2018
Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali
Updated: 4/4/2018
Uitlity of MODS for the Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali
Status: Enrolling
Updated: 4/4/2018
Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali
Updated: 4/4/2018
Uitlity of MODS for the Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali
Updated: 4/4/2018
Uitlity of MODS for the Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali
Status: Enrolling
Updated: 4/4/2018
Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali
Updated: 4/4/2018
Uitlity of MODS for the Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Gene Expression in HIV and Tuberculosis Co-infection
Updated: 4/4/2018
Transcriptional Signature of HIV And TB Co-Infection
Status: Enrolling
Updated: 4/4/2018
Gene Expression in HIV and Tuberculosis Co-infection
Updated: 4/4/2018
Transcriptional Signature of HIV And TB Co-Infection
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Skeletal Muscle Inflammation, Oxidative Stress and DNA Repair in Age-Related Sarcopenia
Updated: 4/4/2018
Claude D. Pepper Older Americans Independence Center (OAIC); Skeletal Muscle Inflammation, Oxidative Stress and DNA Repair in Age-Related Sarcopenia
Status: Enrolling
Updated: 4/4/2018
Skeletal Muscle Inflammation, Oxidative Stress and DNA Repair in Age-Related Sarcopenia
Updated: 4/4/2018
Claude D. Pepper Older Americans Independence Center (OAIC); Skeletal Muscle Inflammation, Oxidative Stress and DNA Repair in Age-Related Sarcopenia
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Streptococcal Infection and Respiratory Distress in Newborns
Updated: 4/4/2018
Respiratory Distress of the Newborn and Its Relationship to Group B Streptococcal Colonization
Status: Enrolling
Updated: 4/4/2018
Streptococcal Infection and Respiratory Distress in Newborns
Updated: 4/4/2018
Respiratory Distress of the Newborn and Its Relationship to Group B Streptococcal Colonization
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Streptococcal Infection and Respiratory Distress in Newborns
Updated: 4/4/2018
Respiratory Distress of the Newborn and Its Relationship to Group B Streptococcal Colonization
Status: Enrolling
Updated: 4/4/2018
Streptococcal Infection and Respiratory Distress in Newborns
Updated: 4/4/2018
Respiratory Distress of the Newborn and Its Relationship to Group B Streptococcal Colonization
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
The Pathogenesis of Hepatitis C Virus Vertical Transmission
Updated: 4/5/2018
The Pathogenesis of Hepatitis C Virus Vertical Transmission
Status: Enrolling
Updated: 4/5/2018
The Pathogenesis of Hepatitis C Virus Vertical Transmission
Updated: 4/5/2018
The Pathogenesis of Hepatitis C Virus Vertical Transmission
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
The Pathogenesis of Hepatitis C Virus Vertical Transmission
Updated: 4/5/2018
The Pathogenesis of Hepatitis C Virus Vertical Transmission
Status: Enrolling
Updated: 4/5/2018
The Pathogenesis of Hepatitis C Virus Vertical Transmission
Updated: 4/5/2018
The Pathogenesis of Hepatitis C Virus Vertical Transmission
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B)
Updated: 4/5/2018
A Phase I Study Using Most Closely HLA-matched BK Virus-specific T Lymphocytes for the Treatment of BK Virus Infections Post-allogeneic Stem Cell Transplant(VIRALYM-B)
Status: Enrolling
Updated: 4/5/2018
Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B)
Updated: 4/5/2018
A Phase I Study Using Most Closely HLA-matched BK Virus-specific T Lymphocytes for the Treatment of BK Virus Infections Post-allogeneic Stem Cell Transplant(VIRALYM-B)
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B)
Updated: 4/5/2018
A Phase I Study Using Most Closely HLA-matched BK Virus-specific T Lymphocytes for the Treatment of BK Virus Infections Post-allogeneic Stem Cell Transplant(VIRALYM-B)
Status: Enrolling
Updated: 4/5/2018
Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B)
Updated: 4/5/2018
A Phase I Study Using Most Closely HLA-matched BK Virus-specific T Lymphocytes for the Treatment of BK Virus Infections Post-allogeneic Stem Cell Transplant(VIRALYM-B)
Status: Enrolling
Updated: 4/5/2018
Click here to add this to my saved trials
Text Message Study
Updated: 4/6/2018
Using Mobile Phone Text Messaging and E-mailing to Decrease Anxiety, Pain, Follow-up Visits and Improve Reporting of Surgical Site Infection After Spine Surgery: A Double-Blind Randomized Trial
Status: Enrolling
Updated: 4/6/2018
Text Message Study
Updated: 4/6/2018
Using Mobile Phone Text Messaging and E-mailing to Decrease Anxiety, Pain, Follow-up Visits and Improve Reporting of Surgical Site Infection After Spine Surgery: A Double-Blind Randomized Trial
Status: Enrolling
Updated: 4/6/2018
Click here to add this to my saved trials
Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients
Updated: 4/9/2018
Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients
Status: Enrolling
Updated: 4/9/2018
Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients
Updated: 4/9/2018
Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients
Status: Enrolling
Updated: 4/9/2018
Click here to add this to my saved trials
Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma
Updated: 4/10/2018
Phase I Study of the Aurora Kinase a Inhibitor MLN8237 in Combination With the Histone Deacetylase Inhibitor Vorinostat in Lymphoid Malignancies
Status: Enrolling
Updated: 4/10/2018
Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma
Updated: 4/10/2018
Phase I Study of the Aurora Kinase a Inhibitor MLN8237 in Combination With the Histone Deacetylase Inhibitor Vorinostat in Lymphoid Malignancies
Status: Enrolling
Updated: 4/10/2018
Click here to add this to my saved trials
Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma
Updated: 4/10/2018
Phase I Study of the Aurora Kinase a Inhibitor MLN8237 in Combination With the Histone Deacetylase Inhibitor Vorinostat in Lymphoid Malignancies
Status: Enrolling
Updated: 4/10/2018
Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma
Updated: 4/10/2018
Phase I Study of the Aurora Kinase a Inhibitor MLN8237 in Combination With the Histone Deacetylase Inhibitor Vorinostat in Lymphoid Malignancies
Status: Enrolling
Updated: 4/10/2018
Click here to add this to my saved trials